Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors
Tumor Biology - United States
doi 10.1177/1010428317695939
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
SAGE Publications